Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin

BACKGROUND: Rhabdomyolysis is an uncommon side effect of trabectedin which is used for the second line therapy of metastatic sarcoma after anthracycline and ifosfamide failure. This side effect may be due to pharmacokinetic interactions caused by shared mechanisms of metabolism involving the cytochr...

Descripción completa

Detalles Bibliográficos
Autores principales: Strippoli, Sabino, Lorusso, Vito, Albano, Anna, Guida, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737021/
https://www.ncbi.nlm.nih.gov/pubmed/23899130
http://dx.doi.org/10.1186/1472-6882-13-199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737021/
https://www.ncbi.nlm.nih.gov/pubmed/23899130
http://dx.doi.org/10.1186/1472-6882-13-199

Ejemplares similares